Involvement of the p38 MAPK signaling pathway in S-phase cell-cycle arrest induced by Furazolidone in human hepatoma G2 cells

Journal of Applied Toxicology

Volumn 33, Issue 12, 2013, Pages 1500-1505

  Sun, Yu ^a   Tang, Shusheng ^a   Jin, Xi ^a   Zhang, Chaoming ^a   Zhao, Wenxia ^a   Xiao, Xilong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Furazolidone; Human hepatoma G2 cells; P38 MAPK; S phase cell cycle arrest

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 6; FURAZOLIDONE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL PROLIFERATION; FURAZOLIDONE; HUMAN HEPATOMA G2 CELLS; P38 MAPK; S-PHASE CELL-CYCLE ARREST;

ANTI-INFECTIVE AGENTS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL CYCLE PROTEINS; CELL PROLIFERATION; FLOW CYTOMETRY; FURAZOLIDONE; HEP G2 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION; S PHASE CELL CYCLE CHECKPOINTS;

EID: 84886096583     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2829     Document Type: Article

References (28)

1. Ali BH. 1999. Pharmacological, therapeutic and toxicological properties of furazolidone: Some recent research. Vet. Res. Commun. 23: 343-360.
2. Bulavin D, Kovalsky O, Hollander MC, Fornace A. 2003. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol. Cell. Biol. 23: 3859-3871.
3. Chen BP, Li M, Asaithamby A. 2011. New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress. Cancer Lett. 326: 2011 Dec 9. [Epub ahead of print].
4. Cheng H, Kartenbeck J, Kabsch K, Mao X, Marqués M, Alonso A. 2002. Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol. J. Cell. Physiol. 192: 234-243.
5. Choi YH, Lee SJ, Nguyen PM, Jang JS, Lee J, Wu ML, Takano E, Maki M, Henkart PA, Trepel JB. 1997. Regulation of cyclin D1 by calpain protease. J. Biol. Chem. 72: 28479-28484.
6. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364: 229-233.
7. Daly JM, Olayioye MA, Wong AM, Neve R, Lane HA, Maurer FG, Hynes NE. 1999. NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways. Oncogene 18: 3440-3451.
8. Eva M, Anke BK, Wolfgang N, Fraek ML, Josefine M, Klaus T, Beck FX. 1999. Possible involvement of heat shock protein 25 in the angiotensin II-induced glomerular mesangial cell contraction via p38 MAP kinase. J. Cell. Physiol. 181: 462-469.
9. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J. 1997. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J. Cell Sci. 110: 357-368.
10. Hedges JC, Dechert MA, Yamboliev IA, Martin JL, Hickey E, Weber LA, Gerthoffer WT. 1999. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J. Biol. Chem. 274: 24211-24219.
11. Hunter T, Pines J. 1994. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582.
12. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S, Han J. 1996. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J. Biol. Chem. 271: 17920-17926.
13. Jin X, Tang SS, Chen Q. 2011. Furazolidone induced oxidative DNA damage via up-regulating ROS that arose cell cycle arrest in human hepatoma G2 cells. Toxicol. Lett. 201: 205-212.
14. Klemke RL, Cai S, Giannini AL, Gallagher PJ, Lanerolle P, Cheresh DA. 1997. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137: 481-492.
15. Kim JY, Choi JA, Kim TH, Yoo YD, Kim JI, Lee YJ, Yoo SY, Cho CK, Lee YS, Lee SJ. 2002. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J. Cell. Physiol. 190: 29-37.
16. Kramer RM, Roberts EF, Strifler BA, Johnstone EM. 1995. Thrombin induces activation of p38 MAP kinase in human platelets. J. Biol. Chem. 270: 27395-27398.
17. Kummer JL, Rao PK, Heidenreich KA. 1997. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272: 20490-20494.
18. Landry J, Huot J. 1995. Modulation of actin dynamics during stress and physiological stimulation by a signaling pathway involving p38 MAP kinase and heat-shock protein 27. Biochem. Cell Biol. 73: 703-707.
19. Lee H, Bai W. 2002. Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol. Cell. Biol. 22: 5835-5845.
20. Matsumoto T, Yokote K, Tamura K, Takemoto M, Ueno H, Saito Y, Mori S. 1999. Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. J. Biol. Chem. 274: 13954-13960.
21. Megan C, Alice G, Patricia W. 2010. A role for p38 stress-activated protein kinase in regulation of cell growth via TORC1. Mol. Cell. Biol. 30: 481-495.
22. Rousseau S, Houle F, Landry J, Huot J. 1997. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15: 2169-2177.
23. Rozengurt E. 1998. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists. J. Cell. Physiol. 177: 507-517.
24. Sanjay K, Bartholomew JV, David JR, Alison MB, Maxine G, John CL. 2001. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. J. Cell. Physiol. 187: 294-303.
25. Win KM, Charlotte F, Mallat A, Cherqui D, Martin N, Mavier P, Preaux AM, Dhumeaux D, Rosenbaum J. 1993. Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. Hepatology 18: 137-145.
26. Yang B, Cao DJ, Sainz I, Colman RW, Guo YL. 2000. Different roles of ERK and p38 MAP kinases during tube formation from endothelial cells cultured in 3-dimensional collagen matrices. J. Cell. Physiol. 200: 360-369.
27. Yu Y, Sato JD. 1999. MAP kinases, phosphatidylinositol 3-kinase, and p70S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J. Cell. Physiol. 178: 235-246.
28. Zou JJ, Chen Q, Tang SS. 2009. Olaquindox-induced genotoxicity and oxidative DNA damage in human hepatoma G2 (HepG2) cells. Mutat. Res. 676: 27-33.